Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis

Antioxidant and antiplatelet activity by polyphenol-rich nutrients: focus on extra virgin olive oil and cocoa

(2016) Lorenzo Loffredo et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease

(2016) Maria Del Ben et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

(2014) Maria Del Ben et al.   BMC GASTROENTEROLOGY

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?

(2014) Zoon Tariq et al.   LIVER INTERNATIONAL

Modern approach to the clinical management of non-alcoholic fatty liver disease

(2014) Maria Del Ben   WORLD JOURNAL OF GASTROENTEROLOGY

Dark Chocolate Acutely Improves Walking Autonomy in Patients With Peripheral Artery Disease

(2014) Lorenzo Loffredo et al.   Journal of the American Heart Association

Oxidative Stress during Development of Alcoholic Fatty Liver: Therapeutic Potential of Cacao Polyphenol

(2013) Koichiro SUZUKI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?

(2012) Y. Yilmaz   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate

(2011) L. Loffredo et al.   HEART

Flavonoid-Rich Cocoa Consumption Affects Multiple Cardiovascular Risk Factors in a Meta-Analysis of Short-Term Studies

(2011) Mark G. Shrime et al.   JOURNAL OF NUTRITION

Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers

(2011) R. CARNEVALE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults

(2010) B. Buijsse et al.   EUROPEAN HEART JOURNAL

Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo

(2010) Joy X. Jiang et al.   GASTROENTEROLOGY

Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis

(2010) Samuele De Minicis et al.   HEPATOLOGY

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atorvastatin Inhibits gp91 phox Circulating Levels in Patients With Hypercholesterolemia

(2009) Pasquale Pignatelli et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults

(2007) Yumi Shiina et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Interstrain differences in susceptibility to non-alcoholic steatohepatitis

(2007) Yuichi Yamazaki et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY